Loading…

Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms

Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. The three human apoE isoforms apoE2, apoE3, and apoE4 only differ in one or two residues. Nevertheless, the functions highly depend on the isoform types and...

Full description

Saved in:
Bibliographic Details
Published in:FEBS letters 2024-04, Vol.598 (8), p.902-914
Main Authors: Ohgita, Takashi, Sakai, Koto, Fukui, Nodoka, Namba, Norihiro, Nakano, Miyu, Kiguchi, Yuki, Morita, Izumi, Oyama, Hiroyuki, Yamaki, Kouya, Nagao, Kohjiro, Kobayashi, Norihiro, Saito, Hiroyuki
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 914
container_issue 8
container_start_page 902
container_title FEBS letters
container_volume 598
creator Ohgita, Takashi
Sakai, Koto
Fukui, Nodoka
Namba, Norihiro
Nakano, Miyu
Kiguchi, Yuki
Morita, Izumi
Oyama, Hiroyuki
Yamaki, Kouya
Nagao, Kohjiro
Kobayashi, Norihiro
Saito, Hiroyuki
description Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. The three human apoE isoforms apoE2, apoE3, and apoE4 only differ in one or two residues. Nevertheless, the functions highly depend on the isoform types and lipidated states. Here, we generated novel anti‐apoE monoclonal antibodies (mAbs) and obtained an apoE4‐selective mAb whose epitope is within residues 110–117. ELISA and bio‐layer interferometry measurements demonstrated that the dissociation constants of mAbs are within the nanomolar range. Using the generated antibodies, we successfully constructed sandwich ELISA systems, which can detect all apoE isoforms or selectively detect apoE4. These results suggest the usability of the generated anti‐apoE mAbs for selective detection of apoE isoforms. Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. Human apoE4 isoform is a risk factor for apoE‐related diseases, although only one or two residues are different in other isoforms. Here, we generated novel anti‐apoE monoclonal antibodies and constructed a sandwich ELISA system to selectively detect the apoE4 isoform.
doi_str_mv 10.1002/1873-3468.14858
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153149425</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3153149425</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2918-a0d43ad988ebf66d1bd5218135428d5511bde92cdb3f6ced1d84ab1e82fc9613</originalsourceid><addsrcrecordid>eNqFkT1PwzAQhi0EoqUws6GMLCn-TOwRqrYgVWLpjOXEFzBK4hCnoDLxE_iN_BLSD7oy3d17z51O9yJ0SfCYYExviExZzHgix4RLIY_Q8KAcoyHGhMciVWyAzkJ4xX0tiTpFAyYFVSmmQ_Q0hxpa0zlfR76Iav8OZWTqzv18fZvGT6PK1z4vfW12cuatgxB1L6aLApSQd66fWEct5P65dp8Qbadc8IVvq3COTgpTBrjYxxFazqbLyX28eJw_TG4XcUMVkbHBljNjlZSQFUliSWYF7W9lglNphSC9AIrmNmNFkoMlVnKTEZC0yFVC2Ahd79Y2rX9bQeh05UIOZWlq8KugGRGMcMWp-B_FnKUSS6V69GqPrrIKrG5aV5l2rf--1wPJDvhwJawPfYL1xhy9sUJvrNBbc_Rseke3GfsF9geC6Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3043780899</pqid></control><display><type>article</type><title>Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms</title><source>Wiley</source><creator>Ohgita, Takashi ; Sakai, Koto ; Fukui, Nodoka ; Namba, Norihiro ; Nakano, Miyu ; Kiguchi, Yuki ; Morita, Izumi ; Oyama, Hiroyuki ; Yamaki, Kouya ; Nagao, Kohjiro ; Kobayashi, Norihiro ; Saito, Hiroyuki</creator><creatorcontrib>Ohgita, Takashi ; Sakai, Koto ; Fukui, Nodoka ; Namba, Norihiro ; Nakano, Miyu ; Kiguchi, Yuki ; Morita, Izumi ; Oyama, Hiroyuki ; Yamaki, Kouya ; Nagao, Kohjiro ; Kobayashi, Norihiro ; Saito, Hiroyuki</creatorcontrib><description>Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. The three human apoE isoforms apoE2, apoE3, and apoE4 only differ in one or two residues. Nevertheless, the functions highly depend on the isoform types and lipidated states. Here, we generated novel anti‐apoE monoclonal antibodies (mAbs) and obtained an apoE4‐selective mAb whose epitope is within residues 110–117. ELISA and bio‐layer interferometry measurements demonstrated that the dissociation constants of mAbs are within the nanomolar range. Using the generated antibodies, we successfully constructed sandwich ELISA systems, which can detect all apoE isoforms or selectively detect apoE4. These results suggest the usability of the generated anti‐apoE mAbs for selective detection of apoE isoforms. Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. Human apoE4 isoform is a risk factor for apoE‐related diseases, although only one or two residues are different in other isoforms. Here, we generated novel anti‐apoE monoclonal antibodies and constructed a sandwich ELISA system to selectively detect the apoE4 isoform.</description><identifier>ISSN: 0014-5793</identifier><identifier>EISSN: 1873-3468</identifier><identifier>DOI: 10.1002/1873-3468.14858</identifier><identifier>PMID: 38529702</identifier><language>eng</language><publisher>England</publisher><subject>amyloid ; apoE isoform ; apolipoprotein E ; brain ; cholesterol ; dissociation ; enzyme-linked immunosorbent assay ; epitopes ; humans ; interferometry ; lipid metabolism ; monoclonal antibody ; sandwich ELISA</subject><ispartof>FEBS letters, 2024-04, Vol.598 (8), p.902-914</ispartof><rights>2024 Federation of European Biochemical Societies.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0009-0002-2631-318X ; 0000-0003-1497-1425</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38529702$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohgita, Takashi</creatorcontrib><creatorcontrib>Sakai, Koto</creatorcontrib><creatorcontrib>Fukui, Nodoka</creatorcontrib><creatorcontrib>Namba, Norihiro</creatorcontrib><creatorcontrib>Nakano, Miyu</creatorcontrib><creatorcontrib>Kiguchi, Yuki</creatorcontrib><creatorcontrib>Morita, Izumi</creatorcontrib><creatorcontrib>Oyama, Hiroyuki</creatorcontrib><creatorcontrib>Yamaki, Kouya</creatorcontrib><creatorcontrib>Nagao, Kohjiro</creatorcontrib><creatorcontrib>Kobayashi, Norihiro</creatorcontrib><creatorcontrib>Saito, Hiroyuki</creatorcontrib><title>Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms</title><title>FEBS letters</title><addtitle>FEBS Lett</addtitle><description>Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. The three human apoE isoforms apoE2, apoE3, and apoE4 only differ in one or two residues. Nevertheless, the functions highly depend on the isoform types and lipidated states. Here, we generated novel anti‐apoE monoclonal antibodies (mAbs) and obtained an apoE4‐selective mAb whose epitope is within residues 110–117. ELISA and bio‐layer interferometry measurements demonstrated that the dissociation constants of mAbs are within the nanomolar range. Using the generated antibodies, we successfully constructed sandwich ELISA systems, which can detect all apoE isoforms or selectively detect apoE4. These results suggest the usability of the generated anti‐apoE mAbs for selective detection of apoE isoforms. Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. Human apoE4 isoform is a risk factor for apoE‐related diseases, although only one or two residues are different in other isoforms. Here, we generated novel anti‐apoE monoclonal antibodies and constructed a sandwich ELISA system to selectively detect the apoE4 isoform.</description><subject>amyloid</subject><subject>apoE isoform</subject><subject>apolipoprotein E</subject><subject>brain</subject><subject>cholesterol</subject><subject>dissociation</subject><subject>enzyme-linked immunosorbent assay</subject><subject>epitopes</subject><subject>humans</subject><subject>interferometry</subject><subject>lipid metabolism</subject><subject>monoclonal antibody</subject><subject>sandwich ELISA</subject><issn>0014-5793</issn><issn>1873-3468</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkT1PwzAQhi0EoqUws6GMLCn-TOwRqrYgVWLpjOXEFzBK4hCnoDLxE_iN_BLSD7oy3d17z51O9yJ0SfCYYExviExZzHgix4RLIY_Q8KAcoyHGhMciVWyAzkJ4xX0tiTpFAyYFVSmmQ_Q0hxpa0zlfR76Iav8OZWTqzv18fZvGT6PK1z4vfW12cuatgxB1L6aLApSQd66fWEct5P65dp8Qbadc8IVvq3COTgpTBrjYxxFazqbLyX28eJw_TG4XcUMVkbHBljNjlZSQFUliSWYF7W9lglNphSC9AIrmNmNFkoMlVnKTEZC0yFVC2Ahd79Y2rX9bQeh05UIOZWlq8KugGRGMcMWp-B_FnKUSS6V69GqPrrIKrG5aV5l2rf--1wPJDvhwJawPfYL1xhy9sUJvrNBbc_Rseke3GfsF9geC6Q</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Ohgita, Takashi</creator><creator>Sakai, Koto</creator><creator>Fukui, Nodoka</creator><creator>Namba, Norihiro</creator><creator>Nakano, Miyu</creator><creator>Kiguchi, Yuki</creator><creator>Morita, Izumi</creator><creator>Oyama, Hiroyuki</creator><creator>Yamaki, Kouya</creator><creator>Nagao, Kohjiro</creator><creator>Kobayashi, Norihiro</creator><creator>Saito, Hiroyuki</creator><scope>NPM</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0009-0002-2631-318X</orcidid><orcidid>https://orcid.org/0000-0003-1497-1425</orcidid></search><sort><creationdate>202404</creationdate><title>Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms</title><author>Ohgita, Takashi ; Sakai, Koto ; Fukui, Nodoka ; Namba, Norihiro ; Nakano, Miyu ; Kiguchi, Yuki ; Morita, Izumi ; Oyama, Hiroyuki ; Yamaki, Kouya ; Nagao, Kohjiro ; Kobayashi, Norihiro ; Saito, Hiroyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2918-a0d43ad988ebf66d1bd5218135428d5511bde92cdb3f6ced1d84ab1e82fc9613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>amyloid</topic><topic>apoE isoform</topic><topic>apolipoprotein E</topic><topic>brain</topic><topic>cholesterol</topic><topic>dissociation</topic><topic>enzyme-linked immunosorbent assay</topic><topic>epitopes</topic><topic>humans</topic><topic>interferometry</topic><topic>lipid metabolism</topic><topic>monoclonal antibody</topic><topic>sandwich ELISA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohgita, Takashi</creatorcontrib><creatorcontrib>Sakai, Koto</creatorcontrib><creatorcontrib>Fukui, Nodoka</creatorcontrib><creatorcontrib>Namba, Norihiro</creatorcontrib><creatorcontrib>Nakano, Miyu</creatorcontrib><creatorcontrib>Kiguchi, Yuki</creatorcontrib><creatorcontrib>Morita, Izumi</creatorcontrib><creatorcontrib>Oyama, Hiroyuki</creatorcontrib><creatorcontrib>Yamaki, Kouya</creatorcontrib><creatorcontrib>Nagao, Kohjiro</creatorcontrib><creatorcontrib>Kobayashi, Norihiro</creatorcontrib><creatorcontrib>Saito, Hiroyuki</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>FEBS letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohgita, Takashi</au><au>Sakai, Koto</au><au>Fukui, Nodoka</au><au>Namba, Norihiro</au><au>Nakano, Miyu</au><au>Kiguchi, Yuki</au><au>Morita, Izumi</au><au>Oyama, Hiroyuki</au><au>Yamaki, Kouya</au><au>Nagao, Kohjiro</au><au>Kobayashi, Norihiro</au><au>Saito, Hiroyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms</atitle><jtitle>FEBS letters</jtitle><addtitle>FEBS Lett</addtitle><date>2024-04</date><risdate>2024</risdate><volume>598</volume><issue>8</issue><spage>902</spage><epage>914</epage><pages>902-914</pages><issn>0014-5793</issn><eissn>1873-3468</eissn><abstract>Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. The three human apoE isoforms apoE2, apoE3, and apoE4 only differ in one or two residues. Nevertheless, the functions highly depend on the isoform types and lipidated states. Here, we generated novel anti‐apoE monoclonal antibodies (mAbs) and obtained an apoE4‐selective mAb whose epitope is within residues 110–117. ELISA and bio‐layer interferometry measurements demonstrated that the dissociation constants of mAbs are within the nanomolar range. Using the generated antibodies, we successfully constructed sandwich ELISA systems, which can detect all apoE isoforms or selectively detect apoE4. These results suggest the usability of the generated anti‐apoE mAbs for selective detection of apoE isoforms. Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. Human apoE4 isoform is a risk factor for apoE‐related diseases, although only one or two residues are different in other isoforms. Here, we generated novel anti‐apoE monoclonal antibodies and constructed a sandwich ELISA system to selectively detect the apoE4 isoform.</abstract><cop>England</cop><pmid>38529702</pmid><doi>10.1002/1873-3468.14858</doi><tpages>13</tpages><orcidid>https://orcid.org/0009-0002-2631-318X</orcidid><orcidid>https://orcid.org/0000-0003-1497-1425</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0014-5793
ispartof FEBS letters, 2024-04, Vol.598 (8), p.902-914
issn 0014-5793
1873-3468
language eng
recordid cdi_proquest_miscellaneous_3153149425
source Wiley
subjects amyloid
apoE isoform
apolipoprotein E
brain
cholesterol
dissociation
enzyme-linked immunosorbent assay
epitopes
humans
interferometry
lipid metabolism
monoclonal antibody
sandwich ELISA
title Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A42%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Generation%20of%20novel%20anti%E2%80%90apoE%20monoclonal%20antibodies%20that%20selectively%20recognize%20apoE%20isoforms&rft.jtitle=FEBS%20letters&rft.au=Ohgita,%20Takashi&rft.date=2024-04&rft.volume=598&rft.issue=8&rft.spage=902&rft.epage=914&rft.pages=902-914&rft.issn=0014-5793&rft.eissn=1873-3468&rft_id=info:doi/10.1002/1873-3468.14858&rft_dat=%3Cproquest_pubme%3E3153149425%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p2918-a0d43ad988ebf66d1bd5218135428d5511bde92cdb3f6ced1d84ab1e82fc9613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3043780899&rft_id=info:pmid/38529702&rfr_iscdi=true